This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: R.sup.1, R.sup.2, R.sup.3, R.sup.4, A and E are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the method of treatment and the use, comprising such compounds for the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), laryngopharyngeal reflux disease, peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of Helicobacter pylori, dyspepsia, functional dyspepsia, Zolli.pi.ger-Ellison syndrome, non-erosive reflux disease (NERD), visceral pain, cancer, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma. ##STR00001##

Koike; Hiroki

Morita; Mikio

laryngopharyngeal reflux/нудота

Benzimidazole derivatives as selective acid pump inhibitors

Найповніша база даних про лікарські трави, підкріплена наукою